|Articles|November 1, 2014
- BioPharm International-11-01-2014
- Volume 27
- Issue 11
BioPharm International, November 2014 Issue (PDF)
Click the title above to open the BioPharm International November 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 11 years ago
Germany Post AMNOG: Insights for BioPharmaabout 11 years ago
Standardizing Practices for Cellular Therapy Manufacturingabout 11 years ago
Setting Standards for Biotech Therapeutics in Indiaabout 11 years ago
Viral Clearance Challenges in Bioprocessingabout 11 years ago
Outside Looking Inabout 11 years ago
Cell Culture Consumables Prevent Contaminationabout 11 years ago
Hype vs. Healthabout 11 years ago
New Era for Generic Drugsabout 11 years ago
DoE Provides Benefits, but Preparation Is Necessaryabout 11 years ago
Vector Manufacturing and Testing for Gene and Cell Therapy ApplicationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
